Showing results (161-170 of 243) with videos related to
Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.Nature Medicine|October 8, 2024
Prediction of brain metastasis development with DNA methylation signaturesJeffrey A Zuccato, Yasin Mamatjan, Farshad Nassiri, et al.European Urology Oncology|November 5, 2025
Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade SamplesRoberto Ruiz-Cordero, Qi Wang, Gayatri Kumar, et al.Cancer Immunology Research|May 3, 2019
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerSangeetha M Reddy, Alexandre Reuben, Souptik Barua, et al.Cancer Medicine|October 5, 2020
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerGrant M Fischer, Fernando C L Carapeto, Aron Y Joon, et al.Cancer|October 26, 2018
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastomaStefania Maraka, Morris D Groves, Aaron G Mammoser, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 3, 2013
Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnosticsRashmi Kanagal-Shamanna, Bryce P Portier, Rajesh R Singh, et al.Neuro-Oncology|August 5, 2011
Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?Jennifer L Clarke, Michele M Ennis, W K Alfred Yung, et al.Neuro-Oncology|December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshopJason T Huse, Max Wallace, Kenneth D Aldape, et al.Nature|October 20, 2015
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowthLin Zhang, Siyuan Zhang, Jun Yao, et al.Pageof 25